GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) » Definitions » 3-Year Revenue Growth Rate

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) 3-Year Revenue Growth Rate : 30.40% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Beijing Wantai Biological Pharmacy Enterprise Co 3-Year Revenue Growth Rate?

Beijing Wantai Biological Pharmacy Enterprise Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.60.

During the past 12 months, Beijing Wantai Biological Pharmacy Enterprise Co's average Revenue per Share Growth Rate was -69.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 30.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 53.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 30.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 11 years, the highest 3-Year average Revenue per Share Growth Rate of Beijing Wantai Biological Pharmacy Enterprise Co was 102.60% per year. The lowest was 9.40% per year. And the median was 22.95% per year.


Competitive Comparison of Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year Revenue Growth Rate falls into.



Beijing Wantai Biological Pharmacy Enterprise Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Beijing Wantai Biological Pharmacy Enterprise Co  (SHSE:603392) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Beijing Wantai Biological Pharmacy Enterprise Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Beijing Wantai Biological Pharmacy Enterprise Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Business Description

Traded in Other Exchanges
N/A
Address
No. 31, Science Park Road, Beiqing Road, Changping District, Beijing, CHN, 102206
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is an engaged in the research and development and production of biodiagnostic reagents and vaccines. The company produces chemiluminescence, nucleic acid, clinical biochemistry and other testing reagents and clinical inspection quality control products and vaccines. Its products include ELISA series, Colloidal gold series, Bole series, Confirmation series, Automatic blood group analyzer and reagent, Chemiluminescence series, Nucleic acid series, and Research Series.

Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Headlines

No Headlines